Natixis Investment Managers International’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-5,333
| Closed | -$467K | – | 41 |
|
|
2018
Q3 | $467K | Sell |
5,333
-3,860
| -42% | -$338K | 0.02% | 485 |
|
|
2018
Q2 | $905K | Buy |
9,193
+674
| +8% | +$66.4K | 0.05% | 302 |
|
|
2018
Q1 | $1.02M | Buy |
8,519
+3,777
| +80% | +$450K | 0.07% | 177 |
|
|
2017
Q4 | $602K | Sell |
4,742
-2,435
| -34% | -$309K | 0.07% | 105 |
|
|
2017
Q3 | $843K | Sell |
7,177
-7,895
| -52% | -$927K | 0.07% | 191 |
|
|
2017
Q2 | $1.2M | Buy |
+15,072
| New | +$1.2M | 0.1% | 140 |
|
|
2017
Q1 | – | Sell |
-8,991
| Closed | -$337K | – | 392 |
|
|
2016
Q4 | $337K | Sell |
8,991
-3,698
| -29% | -$139K | 0.03% | 292 |
|
|
2016
Q3 | $860K | Buy |
12,689
+9,991
| +370% | +$677K | 0.09% | 152 |
|
|
2016
Q2 | $150K | Buy |
+2,698
| New | +$150K | 0.02% | 351 |
|
|
2015
Q4 | – | Sell |
-4,515
| Closed | -$363K | – | 399 |
|
|
2015
Q3 | $363K | Buy |
+4,515
| New | +$363K | 0.05% | 247 |
|
|
2014
Q3 | – | Sell |
-1,004
| Closed | -$63K | – | 187 |
|
|
2014
Q2 | $63K | Hold |
1,004
| – | – | 0.01% | 197 |
|
|
2014
Q1 | $67K | Buy |
+1,004
| New | +$67K | 0.01% | 165 |
|